KaNDy Therapeutics

Stevenage Bioscience Catalyst Incubator Building G
Stevenage
Herts
SG1 2FX
United Kingdom

Tel: 44-0-1438-906-960

Website: http://www.kandytherapeutics.com

About KaNDy Therapeutics

KaNDy Therapeutics was spun out from NeRRe Therapeutics in 2017, and at the same time, all formulation, pre-clinical and clinical safety and efficacy data, and intellectual property associated with NT-814 was transferred to KaNDy Therapeutics.
LEADERSHIP:
Founder, CSO, and COO: Mike Trower
CMO: Steve Pawsey

Currently, there are no jobs for this employer on BioSpace.

Browse jobs with BioSpace Featured Employers here.